Myovant Sciences Ltd (MYOV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2022 | 03-2021 | 03-2020 | 03-2019 | 03-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -205,981 | -255,134 | -288,989 | -273,551 | -143,255 |
| Depreciation Amortization | 5,485 | 3,114 | 3,251 | 2,522 | 905 |
| Accounts receivable | -19,726 | -3,570 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -5,617 | 2,457 | 4,315 | 6,441 | 1,249 |
| Other Working Capital | -107,001 | 584,611 | 21,444 | 27,010 | 13,628 |
| Other Operating Activity | 64,281 | 39,150 | 38,807 | 13,490 | 10,218 |
| Operating Cash Flow | $-268,559 | $370,628 | $-221,172 | $-224,088 | $-117,255 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 23,125 | N/A | N/A | N/A |
| PPE Investments | -974 | -1,773 | -1,099 | -1,236 | -604 |
| Purchase Of Investment | -118,748 | -63,824 | -32,076 | N/A | N/A |
| Sale Of Investment | 101,700 | 33,261 | 29,240 | N/A | N/A |
| Investing Cash Flow | $-18,022 | $-9,211 | $-3,935 | $-1,236 | $-604 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 245,000 | 113,700 | 53,974 | 43,751 |
| Debt Repayment | N/A | N/A | -105,720 | -300 | N/A |
| Common Stock Issued | 24,625 | 6,709 | 137,946 | 220,225 | 1,893 |
| Other Financing Activity | 1,280 | -13,664 | 0 | 0 | 1 |
| Financing Cash Flow | $25,905 | $238,045 | $145,926 | $273,899 | $45,645 |
| Beginning Cash Position | 677,480 | 78,018 | 157,199 | 108,624 | 180,838 |
| End Cash Position | 416,804 | 677,480 | 78,018 | 157,199 | 108,624 |
| Net Cash Flow | $-260,676 | $599,462 | $-79,181 | $48,575 | $-72,214 |
| Free Cash Flow | |||||
| Operating Cash Flow | -268,559 | 370,628 | -221,172 | -224,088 | -117,255 |
| Capital Expenditure | -974 | -1,773 | -1,099 | -1,236 | -604 |
| Free Cash Flow | -269,533 | 368,855 | -222,271 | -225,324 | -117,859 |